Perioperative Management of Patients with Rheumatic Diseases: Glucocorticoids, DMARDs, Biological Agents and NSAIDs

The rheumatic patients are characterized by various structural and functional changes, caused by chronic disease the necessity of constant medication intake, including anti-inflammatory drugs and immunosuppressants. In this regard, the rheumatic patients have an increased risk of intraoperative and postoperative complications. The purpose of this publication is to review current recommendations on the topic of perioperative management of rheumatic patients. The publication consists of two parts. In the first part we review the issues of perioperative administration of steroids, disease-modifying antirheumatic drugs, biologics and nonsteroidal anti-inflammatory drugs.

1. Goodman S.M., Springer B., Guyatt G. et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. Journal of Arthroplasty. 2017; 32(9): 2628-2638. doi: https://doi.org/10.1002/art.40149

2. Gualtierotti R., Parisi M., Ingegnoli F. Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview. Advances in Therapy. 2018; 35(4): 439-456. doi: https://doi.org/10.1007/s12325-018-0686-0

3. Amirdzhanova V.N. Clinical guidelines for the perioperative management of patients with rheumatoid arthritis requiring large joints arthroplasty. Russian Association of Rheumatologists. [Electronic resource]. URL: https://rheumatolog.ru/experts/klinicheskie-rekomendacii. (date of the application: 15.04.2021) [In Russian].

4. Strand V., Ahadieh S., French J. et al. Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials. Arthritis Research & Therapy. 2015; 17. doi: https://doi.org/10.1186/s13075-015-0880-2

5. Singh J.A., Cameron C., Noorbaloochi S. et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015; 386(9990): 258-265. doi: https://doi.org/10.1016/s0140-6736(14)61704-9

6. Bongartz T., Halligan C.S., Osmon D.R. et al. Incidence and Risk Factors of Prosthetic Joint Infection After Total Hip or Knee Replacement in Patients With Rheumatoid Arthritis. Arthritis & Rheumatism-Arthritis Care & Research. 2008; 59(12): 1713-1720. doi: https://doi.org/10.1002/art.24060

7. Hamrahian A.H., Roman S., Milan S. The management of the surgical patient taking glucocorticoids. 2019. [Electronic resource]. URL: https://www.uptodate.com/contents/the-management-of-thesurgical-patient-taking-glucocorticoids?topicRef=1826&source=see_link (date of the application: 15.04.2021).

8. Marik P.E., Varon J. Requirement of Perioperative Stress Doses of Corticosteroids A Systematic Review of the Literature. Archives of Surgery. 2008; 143(12): 1222-1226. doi: https://doi.org/10.1001/archsurg.143.12.1222

9. Tailer K.N., Din K.D. Perioperative management of patients with rheumatic diseases. Rheumatology Secrets. Sterling West GEOTARMedia. 2018; 111-118 [In Russian].

10. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinology and Metabolism Clinics of North America. 2003; 32(2): 367. doi: https://doi.org/10.1016/s0889-8529(03)00008-2

11. Todd G.R. G., Acerini C.L., Ross-Russell R. et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Archives of Disease in Childhood. 2002; 87(6): 457-461. doi: https://doi.org/10.1136/adc.87.6.457

12. Tempark T., Phatarakijnirund V., Chatproedprai S. et al. Exogenous Cushing’s syndrome due to topical corticosteroid application: case report and review literature. Endocrine. 2010; 38(3): 328-334. doi: https://doi.org/10.1007/s12020-010-9393-6

13. Duclos M., Guinot M., Colsy M. et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Medicine and Science in Sports and Exercise. 2007; 39(7): 1036-1043. doi: https://doi.org/10.1249/mss.0b013e31805468d6

14. Kay J., Findling J.W., Raff H. Epidural triamcinolone suppress the pituitary-adrenal axis in human- subjects. Anesthesia and Analgesia. 1994; 79(3): 501-505. doi: https://doi.org/10.1213/00000539-199409000-00017

15. Habib G., Khazin F., Jabbour A. et al. Simultaneous Bilateral Knee Injection of Methylprednisolone Acetate and the Hypothalamic-Pituitary Adrenal Axis: A Single-Blind Case-Control Study. Journal of Investigative Medicine. 2014; 62(3): 621-626. doi: https://doi.org/10.2310/jim.0000000000000048

16. Lansang M.C., Farmer T., Kennedy L. Diagnosing the unrecognized systemic absorbtion of intra-articular and epidural steroid injections. Endocrine Practice. 2009; 15(3): 225-228. doi: https://doi.org/10.4158/ep.15.3.225

17. Hagg E., Asplund K., Lithner F. Value of basal plasma-cortisol assays in the assessment of pituitary-adrenal insufficiency. Clinical Endocrinology. 1987; 26(2): 221-226. doi: https://doi.org/10.1111/j.1365-2265.1987.tb00780.x

18. Schmidt I.L., Lahner H., Mann K., Petersenn S. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. Journal of Clinical Endocrinology & Metabolism. 2003; 88(9): 4193-4198. doi: https://doi.org/10.1210/jc.2002-021897

19. Dekkers O.M., Timmermans J.M., Smit J.W. A. et al. Comparison of the cortisol responses to testing with two doses of ACTH in patients with suspected adrenal insufficiency. European Journal of Endocrinology. 2011; 164(1): 83-87. doi: https://doi.org/10.1530/eje-10-0621

20. Dickstein G., Saiegh L. Low-dose and high-dose adrenocorticotropin testing: indications and shortcomings. Current Opinion in Endocrinology Diabetes and Obesity. 2008; 15(3): 244-249. doi: https://doi.org/10.1097/med.0b013e3282fdf16d

21. Borst G.C., Michenfelder H.J., Obrian J.T. Discordant cortisol response to exogenous ACTH and ibsulin-induced hypoglycmia in patients with pituitary disease. New England Journal of Medicine. 1982; 306(24): 1462-1464. doi: https://doi.org/10.1056/nejm198206173062405

22. Wagner R.L., White P.F., Kan P.B. et al. Inhibition of adrenal steroidogenesis by the anecthetic etomidate. New England Journal of Medicine. 1984; 310(22): 1415-1421. doi: https://doi.org/10.1007/bf03315645

23. Murray H., Marik P.E. Etomidate for endotracheal intubation in sepsis — Acknowledging the good while accepting the bad. Chest. 2005; 127(3): 707-709. doi: https://doi.org/10.1378/chest.127.3.707

24. Amirdzhanova V.N., Makarov M.A., Byalik E.I. et al. Perioperative management of patients with rheumatoid arthritis. Scientific and practical rheumatology. 2014. 52: 366-375. [In Russian] doi: http://dx.doi.org/10.14412/1995-4484-2014-366-375

25. Leopold S.S., Casnellie M.T., Warme W.J. et al. Endogenous cortisol production in response to knee arthroscopy and total knee arthroplasty. Journal of Bone and Joint Surgery-American Volume. 2003; 85A(11): 2163-2167. doi: https://doi.org/10.2106/00004623-200311000-00016

26. Huang Y.M., Wang C.M., Wang C.T. et al. Perioperative celecoxib administration for pain management after total knee arthroplasty — A randomized, controlled study. Bmc Musculoskeletal Disorders. 2008; 9. doi: https://doi.org/10.1186/1471-2474-9-77

27. Axford J.S. Preoperative evaluation and perioperative management of patients with rheumatic diseases. 2021. [Electronic resource]. URL: https://www.uptodate.com/contents/preoperative-evaluationand-perioperative-management-of-patients-with-rheumaticdiseases#H11 (date of the application: 15.04.2021).